167 related articles for article (PubMed ID: 37387446)
1. RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling.
Park SY; Seo D; Jeon EH; Park JY; Jang BC; Kim JI; Im SS; Lee JH; Kim S; Cho CH; Lee YH
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37387446
[TBL] [Abstract][Full Text] [Related]
2. G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of
Zhang J; Wang Y; Shen Y; He P; Ding J; Chen Y
Theranostics; 2018; 8(10):2884-2895. PubMed ID: 29774081
[No Abstract] [Full Text] [Related]
3. RPL17 Promotes Colorectal Cancer Proliferation and Stemness through ERK and NEK2/β-catenin Signaling Pathways.
Ko MJ; Seo YR; Seo D; Park SY; Seo JH; Jeon EH; Kim SW; Park KU; Koo DB; Kim S; Bae JH; Song DK; Cho CH; Kim KS; Lee YH
J Cancer; 2022; 13(8):2570-2583. PubMed ID: 35711835
[No Abstract] [Full Text] [Related]
4. Knockdown of
Zeng Q; Zhang S; He L; Fu Q; Liao L; Chen L; Ding X
Cancer Biother Radiopharm; 2024 Apr; 39(3):236-246. PubMed ID: 37782908
[No Abstract] [Full Text] [Related]
5. Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-κB signaling axis.
Baik IH; Jo GH; Seo D; Ko MJ; Cho CH; Lee MG; Lee YH
Int J Oncol; 2016 Nov; 49(5):1953-1962. PubMed ID: 27633352
[TBL] [Abstract][Full Text] [Related]
6. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.
Klauck PJ; Bagby SM; Capasso A; Bradshaw-Pierce EL; Selby HM; Spreafico A; Tentler JJ; Tan AC; Kim J; Arcaroli JJ; Purkey A; Messersmith WA; Kuida K; Eckhardt SG; Pitts TM
BMC Cancer; 2018 Feb; 18(1):136. PubMed ID: 29402316
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circ_0007142 regulates cell proliferation, apoptosis, migration and invasion via miR-455-5p/SGK1 axis in colorectal cancer.
Wen T; Wu H; Zhang L; Li K; Xiao X; Zhang L; Zhang Y
Anticancer Drugs; 2021 Jan; 32(1):22-33. PubMed ID: 32889894
[TBL] [Abstract][Full Text] [Related]
9. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
10. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
Lu J; Zhang L; Zhou H; Du Z; Zhang G
Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
[No Abstract] [Full Text] [Related]
12. VX-509 attenuates the stemness characteristics of colorectal cancer stem-like cells by regulating the epithelial-mesenchymal transition through Nodal/Smad2/3 signaling.
Yuan Y; Zhang XF; Li YC; Chen HQ; Wen T; Zheng JL; Zhao ZY; Hu QY
World J Stem Cells; 2024 Feb; 16(2):207-227. PubMed ID: 38455101
[TBL] [Abstract][Full Text] [Related]
13. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
14. High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer.
Liao Z; Zhang H; Fan P; Huang Q; Dong K; Qi Y; Song J; Chen L; Liang H; Chen X; Zhang Z; Zhang B
Int J Oncol; 2019 Feb; 54(2):479-490. PubMed ID: 30570110
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
[TBL] [Abstract][Full Text] [Related]
16. miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression.
Chen B; Zhu A; Tian L; Xin Y; Liu X; Peng Y; Zhang J; Miao Y; Wei J
Mol Med Rep; 2018 Jul; 18(1):105-112. PubMed ID: 29749476
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.
You J; Li J; Ke C; Xiao Y; Lu C; Huang F; Mi Y; Xia R; Li Q
Oncogene; 2021 Jun; 40(24):4151-4166. PubMed ID: 34050266
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-875-3p alleviates the progression of colorectal cancer via negatively regulating PLK1 level.
Li SS; Zhu HJ; Li JY; Tian LM; Lv DM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1126-1133. PubMed ID: 32096168
[TBL] [Abstract][Full Text] [Related]
19. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
[TBL] [Abstract][Full Text] [Related]
20. Effects of the CRYAB gene on stem cell-like properties of colorectal cancer and its mechanism.
Dai A; Guo X; Yang X; Li M; Fu Y; Sun Q
J Cancer Res Ther; 2022 Sep; 18(5):1328-1337. PubMed ID: 36204880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
